Novavax Inc (NVAX)
5.86
+0.43
(+7.92%)
USD |
NASDAQ |
Apr 11, 16:00
5.82
-0.04
(-0.68%)
After-Hours: 20:00
Novavax Shareholders Equity (Quarterly): -623.84M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 88.20B |
| Moderna Inc | 10.90B |
| Merck & Co Inc | 46.31B |
| Johnson & Johnson | 71.49B |
| Inovio Pharmaceuticals Inc | 68.50M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.560B |
| Total Liabilities (Quarterly) | 2.184B |
| Debt to Equity Ratio | -0.272 |
| Current Ratio | 0.9779 |
| Net Debt Paydown Yield | -0.03% |